Literature DB >> 3435177

Serum levels of type III collagen aminopropeptide in patients with systemic scleroderma.

S Majewski1, A Skiendzielewska, B Makieła, S Jablońska, M Błaszczyk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3435177     DOI： 10.1007/BF00412596

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN： 0340-3696            Impact factor:   3.017


× No keyword cloud information.
  11 in total

1.  Type III collagen aminopropeptide levels in serum of patients with progressive systemic scleroderma.

Authors:  T Krieg; I Langer; H Gerstmeier; J Keller; H Mensing; G Goerz; R Timpl
Journal:  J Invest Dermatol       Date:  1986-12       Impact factor: 8.551

Review 2.  Scleroderma. A model for fibrosis.

Authors:  R Fleischmajer; J S Perlish; M Duncan
Journal:  Arch Dermatol       Date:  1983-12

Review 3.  The connective tissue in scleroderma.

Authors:  E C LeRoy
Journal:  Coll Relat Res       Date:  1981-04

4.  Secretory phenotypes of endothelial cells in culture: comparison of aortic, venous, capillary, and corneal endothelium.

Authors:  H Sage; P Pritzl; P Bornstein
Journal:  Arteriosclerosis       Date:  1981 Nov-Dec

5.  Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture.

Authors:  J Uitto; E A Bauer; A Z Eisen
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

6.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

7.  Serum and urine analysis of the aminoterminal procollagen peptide type III by radioimmunoassay with antibody Fab fragments.

Authors:  H Rohde; I Langer; T Krieg; R Timpl
Journal:  Coll Relat Res       Date:  1983-09

8.  Scleroderma fibroblasts: some aspects of in vitro assessment of collagen synthesis.

Authors:  T Krieg; C Luderschmidt; L Weber; P K Müller; O Braun-Falco
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

9.  Anticentromere antibody: an immunological marker of a subset of systemic sclerosis.

Authors:  T P Chorzelski; S Jablonska; E H Beutner; M Blaszczyk; M Jarzabek-Chorzelska; D Kencka; S Krasny; V Kumar; A Tchórzewska
Journal:  Br J Dermatol       Date:  1985-10       Impact factor: 9.302

10.  Type III procollagen peptide and PZ-peptidase serum levels in pre-cirrhotic liver diseases.

Authors:  A Morelli; A Vedovelli; S Fiorucci; G P Angelini; C Fini; C A Palmerini; A Floridi
Journal:  Clin Chim Acta       Date:  1985-05-30       Impact factor: 3.786
View more
  3 in total

1.  Markers of collagen and basement membrane metabolism in sera of patients with progressive systemic sclerosis.

Authors:  N G Guseva; N V Anikina; R Myllylä; L Risteli; J Risteli; J V Chochlova; K I Kivirikko; V A Nassonova
Journal:  Ann Rheum Dis       Date:  1991-07       Impact factor: 19.103

2.  Evidence for protein oedema, neutrophil influx, and enhanced collagen production in lungs of patients with systemic sclerosis.

Authors:  N K Harrison; R J McAnulty; P L Haslam; C M Black; G J Laurent
Journal:  Thorax       Date:  1990-08       Impact factor: 9.139

3.  Serum concentration of procollagen type I carboxyterminal propeptide in systemic sclerosis.

Authors:  K Kikuchi; H Ihn; S Sato; A Igarashi; Y Soma; Y Ishibashi; K Takehara
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.